• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

联合使用雌激素和醋酸诺美孕酮停药后岩斜区脑膜瘤消退

Petroclival meningioma regression after combined oestrogen and nomegestrol acetate interruption.

作者信息

Lebeau Julie, Deprez Louis, Pintiaux Axelle, Reuter Gilles

机构信息

CHU de Liège, Liege, Belgium.

Radiodiagnostics, CHU de Liège, Liege, Belgium.

出版信息

BMJ Case Rep. 2025 Jan 19;18(1):e263529. doi: 10.1136/bcr-2024-263529.

DOI:10.1136/bcr-2024-263529
PMID:39828291
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11751604/
Abstract

Meningioma regression after progestin treatment interruption is already established. Zoely is a combined oral contraceptive including oestradiol and progestin (nomegestrol acetate). The effect of combined oestrogen with nomegestrol acetate on meningioma is currently unknown. We report the case of a woman in her early 50s under Zoely for 5 years who was diagnosed with a large petroclival meningioma. After cessation of Zoely, the patient showed clinical improvement and shrinkage of the tumour volume from 27.22 cm to 20.54 cm in 6 months. This is probably the first report of spontaneous meningioma regression after Zoely interruption.

摘要

孕激素治疗中断后脑膜瘤消退的情况已得到证实。佐利是一种复方口服避孕药,含有雌二醇和孕激素(醋酸诺美孕酮)。目前尚不清楚雌二醇与醋酸诺美孕酮联合使用对脑膜瘤的影响。我们报告了一名50岁出头的女性病例,她服用佐利5年,被诊断患有巨大岩斜脑膜瘤。停用佐利后,患者临床症状改善,肿瘤体积在6个月内从27.22立方厘米缩小至20.54立方厘米。这可能是佐利中断后自发性脑膜瘤消退的首例报告。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c58b/11751604/85617aefb5ce/bcr-18-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c58b/11751604/85617aefb5ce/bcr-18-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c58b/11751604/85617aefb5ce/bcr-18-1-g001.jpg

相似文献

1
Petroclival meningioma regression after combined oestrogen and nomegestrol acetate interruption.联合使用雌激素和醋酸诺美孕酮停药后岩斜区脑膜瘤消退
BMJ Case Rep. 2025 Jan 19;18(1):e263529. doi: 10.1136/bcr-2024-263529.
2
Spontaneous regression of meningiomas after interruption of nomegestrol acetate: a series of three patients.醋酸甲羟孕酮停药后脑膜瘤自发消退:三例系列报告。
Acta Neurochir (Wien). 2019 Apr;161(4):761-765. doi: 10.1007/s00701-019-03848-x. Epub 2019 Feb 19.
3
Sustained growth of intraosseous hormone-associated meningiomas after cessation of progestin therapy.孕激素治疗停止后骨内激素相关脑膜瘤的持续生长。
Acta Neurochir (Wien). 2021 Jun;163(6):1705-1710. doi: 10.1007/s00701-021-04781-8. Epub 2021 Mar 2.
4
[Zoely, a combined oral contraceptive, monophasic pill containing estradiol and nomegestrol acetate].佐利,一种复方口服避孕药,含雌二醇和醋酸诺美孕酮的单相片剂。
Rev Med Liege. 2012 Mar;67(3):152-6.
5
Preliminary report of patients with meningiomas exposed to Cyproterone Acetate, Nomegestrol Acetate and Chlormadinone Acetate - Monocentric ongoing study on progestin related meningiomas.接受醋酸环丙孕酮、醋酸诺美孕酮和醋酸氯地孕酮治疗的脑膜瘤患者初步报告——关于孕激素相关性脑膜瘤的单中心正在进行的研究
Clin Neurol Neurosurg. 2021 Nov;210:106959. doi: 10.1016/j.clineuro.2021.106959. Epub 2021 Sep 23.
6
Zoely: a new combined oral contraceptive.佐利:一种新型复方口服避孕药。
Drug Ther Bull. 2014 Aug;52(8):90-3. doi: 10.1136/dtb.2014.8.0270. Epub 2014 Aug 7.
7
Combined hormonal influence of cyproterone acetate and nomegestrol acetate on meningioma: a case report.醋酸环丙孕酮和醋酸诺美孕酮对脑膜瘤的联合激素影响:一例报告
Acta Neurochir (Wien). 2019 Mar;161(3):589-592. doi: 10.1007/s00701-018-03782-4. Epub 2019 Jan 22.
8
Nomegestrol acetate/estradiol: in oral contraception.醋酸诺美孕酮/雌二醇:口服避孕药。
Drugs. 2012 Oct 1;72(14):1917-28. doi: 10.2165/11208180-000000000-00000.
9
Inhibition of ovulation by NOMAC/E2, a novel monophasic oral contraceptive combining nomegestrol acetate and 17β-oestradiol: a double-blind, randomised, dose-finding pilot study.新型单相口服避孕药诺美孕酮/雌二醇(NOMAC/E2,一种结合醋酸诺美孕酮和17β-雌二醇的药物)对排卵的抑制作用:一项双盲、随机、剂量探索性试验研究
Eur J Contracept Reprod Health Care. 2011 Apr;16(2):76-84. doi: 10.3109/13625187.2011.554923. Epub 2011 Feb 21.
10
[Oral combined hormonal contraception containing nomegestrol acetate and 17beta-oestradiol--the statement of Polish Gynecological Society Experts Group].[含醋酸诺美孕酮和17β-雌二醇的口服复方激素避孕药——波兰妇科协会专家组声明]
Ginekol Pol. 2012 Apr;83(4):316-8.

引用本文的文献

1
Oral contraceptives with progestogens desogestrel or levonorgestrel and risk of intracranial meningioma: national case-control study.含去氧孕烯或左炔诺孕酮的口服避孕药与颅内脑膜瘤风险:全国病例对照研究
BMJ. 2025 Jun 11;389:e083981. doi: 10.1136/bmj-2024-083981.

本文引用的文献

1
Prolonged use of nomegestrol acetate and risk of intracranial meningioma: a population-based cohort study.醋酸诺美孕酮的长期使用与颅内脑膜瘤风险:一项基于人群的队列研究。
Lancet Reg Health Eur. 2024 May 17;42:100928. doi: 10.1016/j.lanepe.2024.100928. eCollection 2024 Jul.
2
Extensive androgen exposure and meningioma risk - A matched cohort study.广泛雄激素暴露与脑膜瘤风险 - 一项匹配队列研究。
Clin Neurol Neurosurg. 2024 Apr;239:108217. doi: 10.1016/j.clineuro.2024.108217. Epub 2024 Mar 2.
3
Obesity and meningioma: a US population-based study paired with analysis of a multi-institutional cohort.
肥胖与脑膜瘤:一项基于美国人群的研究及多机构队列分析
J Neurosurg. 2024 Jan 19;140(6):1558-1567. doi: 10.3171/2023.11.JNS23732. Print 2024 Jun 1.
4
The Association Between Meningioma and Breast Cancer: A Systematic Review and Meta-analysis.脑膜瘤与乳腺癌的相关性:系统评价和荟萃分析。
JAMA Netw Open. 2023 Jun 1;6(6):e2318620. doi: 10.1001/jamanetworkopen.2023.18620.
5
Hormone Receptor Expression in Meningiomas: A Systematic Review.脑膜瘤中的激素受体表达:一项系统评价
Cancers (Basel). 2023 Feb 3;15(3):980. doi: 10.3390/cancers15030980.
6
NOMAC-E2 compares to LNG combined oral contraceptives in women over forty: real-world PRO-E2 study.40岁以上女性中诺美孕酮-炔雌醇与左炔诺孕酮复方口服避孕药的比较:真实世界的PRO-E2研究
Gynecol Endocrinol. 2023 Dec;39(1):2166032. doi: 10.1080/09513590.2023.2166032. Epub 2023 Jan 23.
7
Contraception During Perimenopause: Practical Guidance.围绝经期避孕:实用指南
Int J Womens Health. 2022 Jul 15;14:913-929. doi: 10.2147/IJWH.S288070. eCollection 2022.
8
Risk of intracranial meningioma with three potent progestogens: A population-based case-control study.三种强效孕激素致颅内脑膜瘤的风险:基于人群的病例对照研究。
Eur J Neurol. 2022 Sep;29(9):2801-2809. doi: 10.1111/ene.15423. Epub 2022 Jun 20.
9
Use of high dose cyproterone acetate and risk of intracranial meningioma in women: cohort study.大剂量醋酸环丙孕酮的使用与女性颅内脑膜瘤风险:队列研究。
BMJ. 2021 Feb 3;372:n37. doi: 10.1136/bmj.n37.
10
Evolution of the neurosurgical management of progestin-associated meningiomas: a 23-year single-center experience.孕激素相关脑膜瘤的神经外科治疗进展:23 年单中心经验。
J Neurooncol. 2021 Apr;152(2):279-288. doi: 10.1007/s11060-021-03696-9. Epub 2021 Jan 15.